Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 9,500+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

OVERCOMING INDIA'S AMR CHALLENGE

Healthcare Radius

|

June 2024

India faces a growing threat of antimicrobial resistance (AMR). Experts warn of superbugs and ineffective treatments. Is there hope? Read on to find out.

OVERCOMING INDIA'S AMR CHALLENGE

With microbes like bacteria, viruses, and fungi beginning to resist the effects of medicines that were once used to treat them, India faces a formidable antimicrobial resistance (AMR) challenge today. Experts warn of an alarming situation. Dr Honey Savla, Internal Medicine Specialist at Wockhardt Hospitals, Mumbai Central, highlights a “surge in antibiotic-resistant microbes noted in various ICU patients in the country”, a number that’s increasing by roughly 30 percent due to factors like “indiscriminate use of antibiotics, poor de-escalation, wrong durations, dose and frequency.”

Stating that the AMR problem in India is serious, with several challenging factors contributing to the burden, Dr Camilla Rodrigues, Consultant Microbiologist and Chairperson - Infection Control Committee, PD Hinduja Hospital and MRC, says, “The most impacted patients are those in hospitals, particularly the seriously ill in ICUs, adults with co-morbidities such as diabetes, COPD, and CLD, and the immunocompromised (e.g., cancer chemotherapy, transplant patients).”

The uncontrolled use of antibiotics has severe consequences. Dr Rahul Pandit, Chair of the Intensive Care Unit at Sir HN Reliance Hospital, Mumbai, points to the gravity of the issue: "Around 60-70 percent of urinary tract infections which present at the hospital and are complicated, are actually caused by organisms which are resistant." This "community-acquired resistance" translates to critically ill patients arriving at hospitals already infected with resistant strains.

Indiscriminate use of antibiotics, poor de-escalation, wrong durations, dose and frequency are causing a surge in antibiotic resistant microbes in India.

MORE STORIES FROM Healthcare Radius

Healthcare Radius

Healthcare Radius

ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL

Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?

If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.

time to read

3 mins

September 2025

Healthcare Radius

Healthcare Radius

HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY

HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT

Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA

Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI

Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM

SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL

Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS

Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.

time to read

9 mins

September 2025

Listen

Translate

Share

-
+

Change font size